Coronavirus: BioNTech aims to produce 2 billion doses of COVID-19 vaccines in 2021

Published: Updated:
Enable Read mode
100% Font Size

German COVID-19 vaccine maker BioNTech, partner of US pharmaceutical group Pfizer, said on Monday it aims to produce two billion doses of its vaccine this year.

Visit our dedicated coronavirus site here for all the latest updates.

“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label,” BioNTech said in a presentation.

Read more:

EU doubles coronavirus vaccine deal with Pfizer-BioNTech to 600 mln doses

Pfizer/BioNTech vaccine works against new COVID-19 strain, study shows

BioNTech says no data to support delayed COVID-19 vaccine booster shot

Top Content Trending